Neuroendocrine markers of CNS drug effects

Is there a symptomatic distinction between the affective psychoses and schizophrenia? A machine learning approach.

Schizophrenia research·2018

Polygenic risk for schizophrenia, transition and cortical gyrification: a high-risk study.

Psychological medicine·2017

A study of wrist-worn activity measurement as a potential real-world biomarker for late-life depression.

Psychological medicine·2016

Altered hippocampal function in major depression despite intact structure and resting perfusion.

Psychological medicine·2016

Childhood adversity and hippocampal and amygdala volumes in a population at familial high risk of schizophrenia.

Schizophrenia research·2016

The interrelationship between attentional and executive deficits in major depressive disorder.

Acta psychiatrica Scandinavica·2016

Drug-associated central nervous system vasculitis and reversible cerebral vasoconstriction syndrome: A global disproportionality analysis of the WHO pharmacovigilance database (VigiBase).

British journal of clinical pharmacology·2026

Alpha lipoic acid for prevention of radiation-induced dermatitis in breast cancer patients: A randomized-controlled trial.

British journal of clinical pharmacology·2026

Anti-HER2 therapy-associated echocardiography-related cardiac dysfunction and severe outcomes: Comparison of disproportionality and report-level cluster analyses.

British journal of clinical pharmacology·2026

Toward a paradigm of protection through research: Earlier and more ethical inclusion of pregnant and breastfeeding women in clinical trials.

British journal of clinical pharmacology·2026

Acute toxic leucoencephalopathy following protonitazene ingestion.

British journal of clinical pharmacology·2026

The potential impact of H1 antihistamines on clinical outcomes in NSCLC patients undergoing EGFR-TKIs treatment.

British journal of clinical pharmacology·2026

Implementation of the In Vitro Seizure Liability Assay (iLAseizure) in Drug Discovery and Development: Mechanism of Action Case Studies.

Pharmacology research & perspectives·2026

In Silico Evaluation of Annonaceous Acetogenins as Potential HER2 and MELK Inhibitors for Targeted Cancer Therapy.

Anti-cancer agents in medicinal chemistry·2026

Computational Discovery of Phytochemicals Targeting InhA of Mycobacterium tuberculosis: Insights from Molecular Docking, MMGBSA, ADME Profiling, and Molecular Dynamics Simulations.

Current computer-aided drug design·2026

Chalcones as a Platform for the Development of Novel Antiviral Agents: A Review.

Mini reviews in medicinal chemistry·2026

Design of Quinazoline Dual Inhibitors Targeting Focal Adhesion Kinase and Polo-like Kinase 1 for Metastatic Cancers: QSAR, Pharmacophore Modelling, and Molecular Docking Approaches.

Current pharmaceutical design·2026

In-silico Identification of Cyclic Peptide Inhibitors for A42r Profilin-like Protein from Monkeypox Virus.

Current drug targets·2026

Related Experiment Videos

Neuroendocrine markers of CNS drug effects

Related Concept Videos

Is there a symptomatic distinction between the affective psychoses and schizophrenia? A machine learning approach.

Polygenic risk for schizophrenia, transition and cortical gyrification: a high-risk study.

A study of wrist-worn activity measurement as a potential real-world biomarker for late-life depression.

Altered hippocampal function in major depression despite intact structure and resting perfusion.

Childhood adversity and hippocampal and amygdala volumes in a population at familial high risk of schizophrenia.

The interrelationship between attentional and executive deficits in major depressive disorder.

Drug-associated central nervous system vasculitis and reversible cerebral vasoconstriction syndrome: A global disproportionality analysis of the WHO pharmacovigilance database (VigiBase).

Alpha lipoic acid for prevention of radiation-induced dermatitis in breast cancer patients: A randomized-controlled trial.

Anti-HER2 therapy-associated echocardiography-related cardiac dysfunction and severe outcomes: Comparison of disproportionality and report-level cluster analyses.

Toward a paradigm of protection through research: Earlier and more ethical inclusion of pregnant and breastfeeding women in clinical trials.

Acute toxic leucoencephalopathy following protonitazene ingestion.

The potential impact of H1 antihistamines on clinical outcomes in NSCLC patients undergoing EGFR-TKIs treatment.

Implementation of the In Vitro Seizure Liability Assay (iLAseizure) in Drug Discovery and Development: Mechanism of Action Case Studies.

In Silico Evaluation of Annonaceous Acetogenins as Potential HER2 and MELK Inhibitors for Targeted Cancer Therapy.

Computational Discovery of Phytochemicals Targeting InhA of Mycobacterium tuberculosis: Insights from Molecular Docking, MMGBSA, ADME Profiling, and Molecular Dynamics Simulations.

Chalcones as a Platform for the Development of Novel Antiviral Agents: A Review.

Design of Quinazoline Dual Inhibitors Targeting Focal Adhesion Kinase and Polo-like Kinase 1 for Metastatic Cancers: QSAR, Pharmacophore Modelling, and Molecular Docking Approaches.

In-silico Identification of Cyclic Peptide Inhibitors for A42r Profilin-like Protein from Monkeypox Virus.

Related Experiment Videos

Neuroendocrine markers of CNS drug effects

Related Concept Videos

Related Articles